Drug Profile
Research programme: alpha-2 adrenoceptor modulators - Lundbeck
Alternative Names: Alpha2-adrenoceptor modulators research programme - LundbeckLatest Information Update: 25 Jul 2007
Price :
$50
*
At a glance
- Originator Lundbeck Research USA
- Developer Procter & Gamble
- Class
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 17 Mar 2003 Synaptic Pharmaceutical has been acquired by Lundbeck A/S
- 07 Aug 2002 Preclinical trials in Undefined in USA (unspecified route)